Coordinating and delivering research in the pandemic: The UK approachThe acute phase of the COVID-19 pandemic tested the UK’s capacity and capability to rapidly deliver crucial clinical Share XCoordinating and delivering research in the pandemic: The UK approachhttps://pharmaphorum.com/webinars/uk-covid-coronavirus-research-nihr/
Increasing patient engagement with UK clinical trialsPharmaceutical companies often struggle to actively involve patients in the design phase of clinical trials but doing so Share XIncreasing patient engagement with UK clinical trialshttps://pharmaphorum.com/webinars/uk-regulatory-pathway-patient-engagement-trials/
Introducing the new NIHR National Patient Recruitment CentresThe five new NIHR National Patient Recruitment Centres (NPRCs) are set to shape the future of commercial clinical Share XIntroducing the new NIHR National Patient Recruitment Centreshttps://pharmaphorum.com/webinars/nihr-national-patient-recruitment-centres/
Clinical decision-making insights for haem/oncsDespite the effects of countries’ lockdown policies, a plethora of clinical trial readouts continue to emerge providing several Share XClinical decision-making insights for haem/oncshttps://pharmaphorum.com/oncology/clinical-decision-making-insights-haem-oncs/
How to win with a multichannel approach in pharmaA multichannel marketing approach, together with compelling content, is the ultimate way for pharma to deliver the message Share XHow to win with a multichannel approach in pharmahttps://pharmaphorum.com/digital/multichannel-approach-pharma-viseven/
Accelerating pharma’s digital IQ as customer engagement evolvesThe COVID-19 pandemic has brought many changes to the pharmaceutical industry, among them how companies can continue to Share XAccelerating pharma’s digital IQ as customer engagement evolveshttps://pharmaphorum.com/digital/veeva-customer-engagement-webinar/
Unlocking health data to improve oncology outcomesThe NHS’ globally unique health data ecosystem has the potential to improve health outcomes. With around 363,000 new Share XUnlocking health data to improve oncology outcomeshttps://pharmaphorum.com/oncology/unlocking-health-data-to-improve-oncology-outcomes/
The new global digital health paradigm in life sciencesDigital transformation has long been a priority for all life science companies and it has been made even Share XThe new global digital health paradigm in life scienceshttps://pharmaphorum.com/r-d/10-years-in-10-days-the-new-global-digital-health-paradigm-in-life-sciences/
COVID-19 briefing: coronavirus impacts for UK and Ireland pharma and biotechOverview This April webinar is part of IQVIA’s monthly updates on the impact of COVID-19 and its implications Share XCOVID-19 briefing: coronavirus impacts for UK and Ireland pharma and biotechhttps://pharmaphorum.com/r-d/iqvia-covid-19-april-briefing-impact-for-pharma-and-biotech/
